Search by Drug Name or NDC

    NDC 33342-0276-12 Darifenacin 7.5 mg/1 Details

    Darifenacin 7.5 mg/1

    Darifenacin is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is DARIFENACIN HYDROBROMIDE.

    Product Information

    NDC 33342-0276
    Product ID 33342-276_2abbe156-e5ab-484c-aed7-fa4b5f06698d
    Associated GPIs 54100010207520
    GCN Sequence Number 058576
    GCN Sequence Number Description darifenacin hydrobromide TAB ER 24H 7.5 MG ORAL
    HIC3 R1I
    HIC3 Description URINARY TRACT ANTISPASMODIC, M(3) SELECTIVE ANTAG.
    GCN 24043
    HICL Sequence Number 026820
    HICL Sequence Number Description DARIFENACIN HYDROBROMIDE
    Brand/Generic Generic
    Proprietary Name Darifenacin
    Proprietary Name Suffix n/a
    Non-Proprietary Name Darifenacin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 7.5
    Active Ingredient Units mg/1
    Substance Name DARIFENACIN HYDROBROMIDE
    Labeler Name Macleods Pharmaceuticals Limited
    Pharmaceutical Class Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207302
    Listing Certified Through 2024-12-31

    Package

    NDC 33342-0276-12 (33342027612)

    NDC Package Code 33342-276-12
    Billing NDC 33342027612
    Package 10 BLISTER PACK in 1 CARTON (33342-276-12) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2017-07-29
    NDC Exclude Flag N
    Pricing Information N/A